491 results on '"Stevens, Scott M."'
Search Results
2. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
3. Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry
4. Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound
5. The Risk Assessment Profile is suboptimal for guiding duplex ultrasound surveillance in trauma patients
6. Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19
7. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
8. Performance of a Prospective Anticoagulation Stratification Algorithm After Liver Transplantation
9. Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation
10. Post‐discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers
11. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta‐analysis
12. Predicting postdischarge hospital‐associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers
13. Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncope
14. In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation
15. Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM‐DVT): Methods of a prospective single‐arm management study
16. Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study
17. Excluding pregnancy-associated DVT with whole-leg ultrasound
18. A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
19. Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals
20. Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: A double-blind, randomized, pilot study
21. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism
22. Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers
23. Integrating Research, Quality Improvement, and Medical Education for Better Handoffs and Safer Care: Disseminating, Adapting, and Implementing the I-PASS Program
24. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation
25. Automated Analysis of Short Responses in an Interactive Synthetic Tutoring System for Introductory Physics
26. THROMBOEMBOLISM-RISK-BASED ALGORITHM DECREASES ANTICOAGULATION RATES AND BLEEDING RISK AFTER LIVER TRANSPLANTATION
27. Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients
28. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation
29. Follow-up of Incidental Pulmonary Nodules and the Radiology Report
30. Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools
31. Synoptic reporting accuracy for computed tomography pulmonary arteriography among patients suspected of pulmonary embolism
32. Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
33. P9.18: Decreasing Therapeutic Anticoagulation and Bleeding in Post-operative Liver Transplant Patients: A Single Institution’s Analysis of a Prospective Anticoagulation Algorithm
34. From 3 months to forever – oral contraceptives, venous thrombosis and duration of anticoagulation. A challenging decision
35. Follow-up of Incidental Pulmonary Nodules and the Radiology Report
36. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
37. Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients with Non-Valvular Atrial Fibrillation (Cognitive Decline and Dementia in Patients with Non-Valvular Atrial Fibrillation (CAF) Trial)
38. Student Question-Asking Patterns in an Intelligent Algebra Tutor
39. Randomized Trial of Physician Alerts for Thromboprophylaxis after Discharge
40. Adherence to PIOPED II Investigators' Recommendations for Computed Tomography Pulmonary Angiography
41. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial
42. Patterns and Appropriateness of Thrombophilia Testing in an Academic Medical Center
43. Thrombophilic Evaluation in Patients with Acute Pulmonary Embolism: Controversies and Evolving Concepts in Deep Venous Thrombosis and Pulmonary Embolism
44. Role of thrombophilia testing: con
45. Derivation and Validation of a Simple Model to Identify Venous Thromboembolism Risk in Medical Patients
46. Executive Summary
47. Antithrombotic Therapy for VTE Disease
48. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Initiative: A Summary and Review of Peripherally Inserted Central Catheter and Venous Catheter Appropriate Use
49. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report
50. Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.